StockData
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. (PRAX) stock

PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$310.90+5.71 (+1.87%)

Close on Nov 19, 2026Market cap $8.68BP/E –Yield –

Praxis Precision Medicines free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Praxis Precision Medicines's free cash flow for the twelve months ending Jun 30, 2026 was -$305.38M. For fiscal 2025 it was -$249.12M. The highest annual figure on record is -$33.52M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$249.12M–
FY2024Dec 31, 2024-$131.76M–
FY2023Dec 31, 2023-$111.19M–
FY2022Dec 31, 2022-$185.49M–
FY2021Dec 31, 2021-$125.60M–
FY2020Dec 31, 2020-$52.62M–
FY2019Dec 31, 2019-$33.52M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$77.79M–
Q1 FY2026Mar 31, 2026-$86.21M–
Q4 FY2025Dec 31, 2025-$76.33M–
Q3 FY2025Sep 30, 2025-$65.06M–
Q2 FY2025Jun 30, 2025-$54.73M–
Q1 FY2025Mar 31, 2025-$53.01M–
Q4 FY2024Dec 31, 2024-$56.12M–
Q3 FY2024Sep 30, 2024-$27.50M–
Q4 FY2023Dec 31, 2023-$23.91M–
Q3 FY2023Sep 30, 2023-$23.22M–
Q2 FY2023Jun 30, 2023-$31.21M–
Q1 FY2023Mar 31, 2023-$32.85M–
Q4 FY2022Dec 31, 2022-$28.81M–
Q3 FY2022Sep 30, 2022-$44.96M–
Q2 FY2022Jun 30, 2022-$57.32M–
Q1 FY2022Mar 31, 2022-$54.40M–
Q4 FY2021Dec 31, 2021-$45.39M–
Q3 FY2021Sep 30, 2021-$24.41M–
Q2 FY2021Jun 30, 2021-$30.08M–
Q1 FY2021Mar 31, 2021-$25.73M–
Q4 FY2020Dec 31, 2020-$20.23M–
Q3 FY2020Sep 30, 2020-$13.88M–
Q2 FY2020Jun 30, 2020-$9.94M–
Q1 FY2020Mar 31, 2020-$8.57M–
Q4 FY2019Dec 31, 2019-$9.95M–

More Praxis Precision Medicines figures

See a number that looks wrong?